XML 30 R20.htm IDEA: XBRL DOCUMENT
v3.23.3

Earnings Per Share | 9 Months Ended
--- | ---
Sep. 30, 2023
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share The following table summarizes earnings per share calculations:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2023 |  | 2022 |  | 2023 |  | 2022
Basic earnings per common share |  |  |  |  |  |  |
Net income attributable to Quaker Chemical Corporation | $ | 33,670 |  |  | $ | 25,867 |  |  | $ | 92,550 |  |  | $ | 60,026 |
Less: income allocated to participating securities | (164) |  |  | (115) |  |  | (464) |  |  | (250) |
Net income available to common shareholders | $ | 33,506 |  |  | $ | 25,752 |  |  | $ | 92,086 |  |  | $ | 59,776 |
Basic weighted average common shares outstanding | 17,908,754 |  | 17,847,305 |  | 17,889,444 |  | 17,835,976
Basic earnings per common share | $ | 1.87 |  |  | $ | 1.44 |  |  | $ | 5.15 |  |  | $ | 3.35 |
Diluted earnings per common share |  |  |  |  |  |  |
Net income attributable to Quaker Chemical Corporation | $ | 33,670 |  |  | $ | 25,867 |  |  | $ | 92,550 |  |  | $ | 60,026 |
Less: income allocated to participating securities | (164) |  |  | (115) |  |  | (464) |  |  | (250) |
Net income available to common shareholders | $ | 33,506 |  |  | $ | 25,752 |  |  | $ | 92,086 |  |  | $ | 59,776 |
Basic weighted average common shares outstanding | 17,908,754 |  | 17,847,305 |  | 17,889,444 |  | 17,835,976
Effect of dilutive securities | 12,520 |  | 12,566 |  | 16,709 |  | 15,465
Diluted weighted average common shares outstanding | 17,921,274 |  | 17,859,871 |  | 17,906,153 |  | 17,851,441
Diluted earnings per common share | $ | 1.87 |  |  | $ | 1.44 |  |  | $ | 5.14 |  |  | $ | 3.35 |
Certain stock options, restricted stock units, and PSUs are not included in the diluted earnings per share calculation when the effect would have been anti-dilutive. The calculated amount of anti-diluted shares not included were 11,598 and 10,453 for the three and nine months ended September 30, 2023, respectively, and 25,896 and 24,618 for the three and nine months ended September 30, 2022, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration